ArticleThe Lancet. Rheumatology2025

Survival in patients with rheumatoid arthritis and recently diagnosed early-stage colorectal, lung, or prostate cancer receiving tumour necrosis factor inhibitors: a retrospective cohort study.

Juan I Ruiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.